7
Participants
Start Date
July 7, 2023
Primary Completion Date
July 1, 2025
Study Completion Date
December 1, 2025
Placebo
Placebo (intravenous infusion)
PF-06823859
PF-06823859 (intravenous infusion)
Ionos Dragoumi 5 Kaisariani, Kaisarianí
Hospital Universitario 12 de Octubre, Madrid
Emory University, Atlanta
The Kirklin Clinic of UAB Hospital, Birmingham
University of Alabama at Birmingham - School of Medicine, Birmingham
University of Alabama at Birmingham, Department of Dermatology, Birmingham
The University of Alabama at Birmingham, Birmingham
Hospital Universitario Virgen Del Rocio, Seville
Cleveland Clinic Foundation, Cleveland
The University of Kansas Hospital, Kansas City
University of Kansas Medical Center, Kansas City
Mayo Clinic Hospital, Phoenix
Mayo Clinic in Arizona - Scottsdale, Scottsdale
Dermatology Research Associates, Los Angeles
DermEffects, London
Dermatology on Bloor - Research Toronto, Toronto
Oshawa Clinic Dermatology Trials, Whitby
Attikon General University Hospital, Chaïdári
Dermatological and Venereological Hospital Andreas Syggros, Athens
Lead Sponsor
Pfizer
INDUSTRY